Online Brochure

T-Series PFAS Consulting

The PFAS Challenge

our organisation faces mounting PFAS pressure:

  • Tightening regulations (DWI, EA) with punitive non-compliance costs.

  • Unknown contamination extent across your estate.

  • Treatment CAPEX uncertainty - £100k to £10m+ per site.

  • Operational disruption and reputational exposure.

  • Technology selection paralysis - which solution actually works?

The risk of getting it wrong: Over-engineering wastes millions. Under-engineering triggers regulatory action, unforeseen outcomes and remediation costs that dwarf initial investment.

You need clarity, confidence and a roadmap that optimises both risk and capital.

The T-Series Solution Framework

From uncertainty to optimised implementation in defined stages

Our end-to-end framework gives you control at every decision point:

Phase 1: Know Your Risk → Rapid assessment to priority-rank your exposure.

Phase 2: Build Your Strategy → Technically-validated roadmap with investment-grade options.

Phase 3: Design for Success → Procurement-ready specifications that vendors can't inflate.

Phase 4: Optimise Operations → Ongoing performance assurance and cost reduction.

Why staged? You invest progressively as certainty increases. Exit points at every tier. Commercial levers (up to 100% T2/T3 creditable against T3/T4).

Phase 1 – Know Your Risk

T1 – PFAS Risk & Opportunity Snapshot

Fast triage for 1-2 sites – know where you stand in 2 weeks.

What you get:

  • Quantified PFAS "hot-spot" map across your site(s).

  • Mass-balance validated exposure assessment.

  • Risk-ranked priority action register.

  • 10–15-page executive report with defendable next steps.

Outcome: Board-ready clarity on whether you have a £50k problem or a £5m problem.

Investment: Contact us for pricing.

Commercial lever: 50-100% creditable against T2/T3.

T2 – Baseline Assessment & PFAS Roadmap

Deep-dive technical strategy with investment-ready options.

What you get:

  • Site visit, sampling strategy and 2Encapsulate lab analysis.

  • Validated mass-balance and discharge pathway mapping.

  • 2-3 technically-costed treatment options (CAPEX/OPEX ranges).

  • Compliance and permitting roadmap with timeline.

  • Sensitivity analysis on key variables.

Outcome: Investment committee-ready business case with risk-adjusted options.

Investment: Contact us for pricing.

Phase 2 – Design & Deliver

T3 – Detailed Treatment & Transition Design

From roadmap to procurement-ready engineering.

What you get:

  • Detailed treatment concept (IX/regeneration, EboNext - AEOP, GAC, foam fractionation, hybrid).

  • PFD/P&ID-level integration with existing assets.

  • Vendor-independent specifications (stops scope creep).

  • Refined CAPEX/OPEX model with sensitivity scenarios.

  • Procurement support and investment paper.

Outcome: Tender documents that attract competitive bids and prevent cost inflation.

Investment: Contact us for pricing.

T4 – Implementation & Technical Advisory Retainer

Ongoing design review, commissioning support and optimisation.

What you get:

  • Design/vendor review and commissioning oversight.

  • Performance dashboard and regulatory horizon scanning.

  • Troubleshooting and optimisation recommendations.

  • Quarterly advisory reviews.

Outcome: Confident operation, proactive compliance, continuous cost reduction.

Investment:

  • Light retainer: Contact us for pricing.

  • Standard: Contact us for pricing.

  • Strategic (multi-site): Contact us for pricing.

Specialist Capabilities (Add-Ons)

Accelerate outcomes with targeted expertise:

  • Regulatory & Permitting (DWI, EA, Reg 31/27).

  • EboNext Vortex Cell / AEOP Characterisation.

  • Rapid Small-Scale Column Testing.

  • Analytics & Lab Strategy / PFAS Methods.

  • Training & Culture Change.

  • Funding & Grants Support.

  • ESA Phase 1/2 Studies.

These modules integrate at any tier – deployed when you need them, not before.

Choosing Your Entry Point

Where are you now?

"Just becoming aware of PFAS risk"

Start at T0.1 Discovery Call (Free) or T0.2 Executive Briefing.

"Suspect PFAS but have limited data"

Start at T1 Risk Snapshot – fast, low-cost triage.

"Know we have PFAS; need a strategy"

Start at T2 Baseline & Roadmap – full investment-grade options.

"Ready to invest in treatment/upgrade"

Start at T3 Detailed Design – de-risk procurement.

"Systems being implemented or running"

Start at T4 Advisory Retainer – optimise and future-proof.

Not sure? Book a T0.1 Discovery Call – we'll recommend the right entry tier.

Why clients choose 2Encapsulate

✓ Vendor-independent – technology-agnostic advice that saves you money.

✓ Scientifically-led – in-house lab, piloting capability, published expertise.

✓ Commercially flexible – creditable fees, staged investment, outcome-aligned.

✓ End-to-end – from first awareness call to multi-year optimisation.

✓ Regulatory confidence – deep EA/DWI engagement experience.

Next Steps

Let's Start the Conversation

  1. Book a T0.1 PFAS Discovery Call (Free, 30-60 min).

  2. Clarify your context and regulatory drivers.

  3. Identify suspected PFAS sources.

  4. Receive short email summary with recommended T-Series entry point.

Acronyms clarified

  • PFAS (Per- and polyfluoroalkyl substances)

  • DWI (Drinking Water Inspectorate)

  • EA (Environment Agency)

  • CAPEX (Capital Expenditure)

  • OPEX (Operational Expenditure)

  • PFD (Process Flow Diagram)

  • P&ID (Piping and Instrumentation Diagram)

  • IX (Ion Exchange)

  • AEOP (Advanced Electrochemical Oxidation Process)

  • GAC (Granular Activated Carbon)

  • ESA (Environmental Site Assessment)

Take Action